The pharmaceutical excipient powerhouse will highlight its
latest advancements including controlled release, pediatric and
novel delivery formats to meet Japan's diverse formulation needs
TOKYO, March 25,
2024 /PRNewswire/ -- IFF, a global leader in food and
beverage, home and personal care and health, will present its broad
portfolio and latest excipient technology to CPhI Japan 2024 at
booth 5K21, Tokyo Big Sight, Tokyo
from April 17-19.
IFF's Pharma Solutions offers high-quality pharmaceutical solutions
backed by extensive research and expertise. The team will showcase
its comprehensive cellulosic-derived excipients portfolio of
innovative solutions, from binders and disintegrants to lubricants
and matrix systems across the immediate release, controlled
release, pediatric and novel delivery formulations.
"As a first-time participant at CPhI Japan, we are excited about
the opportunity to connect with customers and industry peers," said
Frank Zhao, commercial leader,
Asia-Pacific, Pharma Solutions,
IFF. "This event provides us with a valuable opportunity to
showcase our innovative offerings and demonstrate our commitment to
driving advancements in pharmaceutical development."
In addition to highlighting its latest innovation, IFF's team of
technical experts will also host an information session to
introduce Ac-Di-Sol® SD-711. The session titled, "Disintegration
Mechanism Analysis of Croscarmellose Sodium and its Application to
Orally Disintegrating Tablet Formulation", will take place on
April 17, from 4:00 - 4:30 p.m. in room 6C05. Customers will
gain insights into the capabilities and benefits of high-performing
excipient solutions and explore potential collaborations to address
their toughest challenges.
As a trusted partner to pharmaceutical manufacturers worldwide,
IFF will present its latest advancements in excipient technology
including:
- Super disintegrant Ac-Di-Sol® – possesses
exceptional water uptake and rapid swelling properties, supports
faster disintegration and drug dissolution at lower use levels in
oral disintegrating tablets (ODT).
- Multiparticulate tablet Avicel® PH and Silicified
Microcrystalline Cellulose (SMCC) – acts as an efficient
cushioning agent to enable desired tablet hardness and prevent
damage to pellets' coating layer.
- Low nitrite microcrystalline cellulose Avicel® PH LN –
reduces the risk of N-nitrosamine formation in oral solid dosage
formulations.
- VERDIGEL™ SC – an innovative carrageenan-free
technology for superior vegan pectin softgel quality, performance,
and process efficiency.
Combining its deep expertise in excipients, innovation
capabilities, and regulatory services, IFF offers an integrated
solutions platform for customer support at every step of their
formulation journey. To learn more about IFF's broad portfolio and
proven expertise, visit https://pharma.iff.com.
Welcome to IFF
At IFF (NYSE: IFF), an industry leader in food, beverage,
health, biosciences and scent, science and creativity meet to
create essential solutions for a better world – from global icons
to unexpected innovations and experiences. With the beauty of art
and the precision of science, we are an international collective of
thinkers who partner with customers to bring scents, tastes,
experiences, ingredients and solutions for products the world
craves. Together, we will do more good for people and planet. Learn
more at iff.com, Twitter , Facebook, Instagram,
and LinkedIn.
©2024 International Flavors & Fragrances Inc. (IFF). IFF,
the IFF Logo, and all trademarks and service marks denoted with ™,
℠ or ® are owned by IFF or affiliates of IFF unless otherwise
noted. All Rights Reserved.
SOURCE IFF